July 2020

Abbott’s Personalized Chronic Pain Therapy App Approved by FDA

iStockphoto.com #1215848398

Abbott, Abbott Park, IL, has received approval to use its iOS-compatible St. Jude Medical Patient Controller Application, which is available for download from the Apple store. This app is for people living with chronic pain and neurologic disorders who are treated by Abbott neuromodulation devices including Infinity DBS System for patients with Parkinson’s disease or essential tremor, Proclaim XR SCS System for patients with chronic pain, and Proclaim DRG Neurostimulation System for patients with chronic pain in the lower limbs caused by complex regional pain syndrome or causalgia. Patients can now use the app rather than the separate controller that has been used to adjust the company’s neuromodulation products.

The app allows physicians to interact with and treat their patients remotely; multiple prescribed programs can be saved to the app. The app is easy to use, allows patients to manage neuromodulation therapy, such as selecting prescribed stimulation settings and adjusting stimulation amplitude. The app will automatically connect to the patient’s neurostimulation device upon being opened.

According to the app manual, the minimum system requirements for the Patient Controller app is a 5th generation Apple iPod touch running iOS software 9.3.1 or later. Cybersecurity measures have been implemented in the app.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.